Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tadeusz Skarzynski

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Acta Crystallographica. Section D, Biological Crystallography|June 25, 2013
Collecting data in the home laboratory: evolution of X-ray sources, detectors and working practicesTadeusz Skarzynski
Acta Crystallographica. Section D, Biological Crystallography|December 22, 2005
Industrial perspective on X-ray data collection and analysisTadeusz Skarzynski, James Thorpe
Protein Science : a Publication of the Protein Society|June 19, 2013
Crystal structures of ASK1-inhibtor complexes provide a platform for structure-based drug designOnkar Singh, Anthony Shillings, Peter Craggs, et al.
Organic Letters|November 25, 2003
Pyrrolidine-5,5-trans-lactams. 4. Incorporation of a P3/P4 urea leads to potent intracellular inhibitors of hepatitis C virus NS3/4A proteaseMartin J Slater, Elizabeth M Amphlett, David M Andrews, et al.
Organic Letters|December 6, 2002
Pyrrolidine-5,5-trans-lactams. 2. The use of X-ray crystal structure data in the optimization of P3 and P4 substituentsDavid M Andrews, Helene Chaignot, Barry A Coomber, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Acta Crystallographica. Section D, Biological Crystallography|June 25, 2013
Collecting data in the home laboratory: evolution of X-ray sources, detectors and working practicesTadeusz Skarzynski
Acta Crystallographica. Section D, Biological Crystallography|December 22, 2005
Industrial perspective on X-ray data collection and analysisTadeusz Skarzynski, James Thorpe
Protein Science : a Publication of the Protein Society|June 19, 2013
Crystal structures of ASK1-inhibtor complexes provide a platform for structure-based drug designOnkar Singh, Anthony Shillings, Peter Craggs, et al.
Organic Letters|November 25, 2003
Pyrrolidine-5,5-trans-lactams. 4. Incorporation of a P3/P4 urea leads to potent intracellular inhibitors of hepatitis C virus NS3/4A proteaseMartin J Slater, Elizabeth M Amphlett, David M Andrews, et al.
Organic Letters|December 6, 2002
Pyrrolidine-5,5-trans-lactams. 2. The use of X-ray crystal structure data in the optimization of P3 and P4 substituentsDavid M Andrews, Helene Chaignot, Barry A Coomber, et al.
Pageof 1